TrialClinical research in cardiology : official journal of the German Cardiac Society2016

Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.

Salvatore Cassese et al.PubMed ↗Publisher ↗

No numbers read from the abstract.